Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

Clinical trial NCT00970307 · COMPLETED

Trial details

NCT number: NCT00970307
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tetanus Diphtheria Haemophilus Influenzae Type b Poliomyelitis Acellular Pertussis Hepatitis B Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni

Start date: 2009-08-13
Primary completion: 2010-01-27
Enrollment: 421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.